Radiation recall dermatitis with pemetrexed. Incidental localized (solitary) mediastinal malignant mesothelioma. [Diseases caused by asbestos dust and the trend of their development in exposed workers in 1951-2003] Serum PDGF-AB in Pleural Mesothelioma. Mesothelioma: treatment and survival of a patient population and review of the literature. Open-label study of pemetrexed alone or in combination with Cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Risk assessment for asbestos-related cancer from the 9/11 attack on the World Trade Center. Mesothelial inclusion cysts (so-called benign cystic mesothelioma)--a clinicopathological analysis of six cases. Pharmacological modulation of lung cancer cells for potassium ion depletion. Mutational analysis of 9 different tumour-associated genes in human malignant mesothelioma cell lines. Receptor tyrosine kinase and phosphoinositide-3 kinase signaling in malignant mesothelioma. Assessment of environmental and domestic exposure to tremolite in New Caledonia. [The role of surgery for the treatment of malignant pleural mesothelioma] The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study. Malignant mesothelioma. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Common EGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma. Case report: Malignant peritoneal mesothelioma in two siblings. Gene therapy of mesothelioma. [A case of malignant mesothelioma showing rapid progression during one month] Prognostic significance of Bax and Fas Ligand in erionite and asbestos induced Turkish malignant pleural mesothelioma. Malignant mesothelioma of the tunica vaginalis. Extrapolation of the carcinogenic potency of fibers from rats to humans. CT in differential diagnosis of benign and malignant pleural disease. Occupational asbestos exposure and predictable asbestos-related diseases in India. A molecular epidemiology case control study on pleural malignant mesothelioma. Intensity-modulated radiation therapy for mesothelioma: Impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency. Pseudomesotheliomatous presentation of primary signet ring cell carcinoma of lung. Clear cell mesothelioma presenting as an incarcerated abdominal hernia. Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases. Multiple primary intrathoracic neoplasms: case report and a review of the literature. Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma. A review of the toxicology and epidemiology of wollastonite. [Benign cystic mesothelioma, a rare tumor of the peritoneum] Chromosomal alterations in early stages of malignant mesotheliomas. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma. [Spinal cord compression from a malignant pleural mesothelioma] Primary neoplasms of peritoneal and sub-peritoneal origin: CT findings. Primary diagnosis of malignant mesothelioma by fine-needle aspiration of a supraclavicular lymph node. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas. Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling. Triplet Chemotherapy with Cisplatin, Gemcitabine and Vinorelbine for Malignant Pleural Mesothelioma. A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma. Localized visceral invasion of peritoneal mesothelioma causing intestinal obstruction: a new clinical presentation. A rare case of solitary fibrous tumour of the pre-sacral space: morphological and immunohistochemical features. Malignant peritoneal mesothelioma. Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso. Activation and relocalization of caspase 3 during the apoptotic cascade of human mesothelioma cells. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. [Wonder matter and assassin. The perception of the asbestos danger as a mirror of the time 1930-1990.] New agents in the management of advanced mesothelioma. [Treatment of thoracic malignancy : results of meta-analyses.] The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Residential Proximity to Naturally Occurring Asbestos and Mesothelioma Risk in California. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma. Pemetrexed disodium. Expression of mesothelial markers in malignant mesotheliomas: an immunohistochemical evaluation of 173 cases. Localized malignant mesothelioma. Validation of genomics-based prognostic tests in malignant pleural mesothelioma. Up-regulation of EphB4 in mesothelioma and its biological significance. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Limited efficacy of imatinib mesylate in malignant mesothelioma: A phase II trial. Transcriptional profiling of mesothelioma using microarrays. Implications of P16/CDKN2A deletion in pleural mesotheliomas. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience. Treatment planning system evaluation for mesothelioma IMRT. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience. Molecular prognostic markers in malignant mesothelioma. Malignant pleural mesothelioma: staging systems. Computerized analysis of mesothelioma on CT scans. CT, RECIST, and malignant pleural mesothelioma. Asbestos and mesothelioma: worldwide trends. The role of PET in the surgical management of malignant pleural mesothelioma. Epidemic of mesothelioma in Egypt. Overview on ongoing or planned clinical trials in Europe. Clinical trials in malignant pleural mesothelioma in Australasia. Soluble mesothelin-related protein--a blood test for mesothelioma. Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases. New therapeutic options for mesothelioma. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. Malignant mesothelioma in Hong Kong. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. Management of malignant pleural effusions. Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma. [Chronic abdominal pain and peritoneal mesothelioma: case report] [Registry of occupational respiratory diseases in Navarre.] [Malign pleural mesothelioma] [Benign pleural diseases induced by asbestos] Palliative intracavitary carboplatin therapy in a cat with suspected pleural mesothelioma. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. Two-chamber intracardiac mesothelioma. [Therapeutic options in malignant pleural mesothelioma] Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study. Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Solitary fibrous tumour of the epididymis: MRI features. [Malignant cardiac tumors] Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients. Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase. An autopsy case of primary pericardial mesothelioma in arc cutter exposed to asbestos through talc pencils. Prognostic factors in mesothelioma. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients. Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research. Silicone thorax due to a ruptured breast implant. Sentinel lymph node mapping of the pleural space. Angiotrophic intravascular lymphosarcoma presenting as bi-cavity effusion in a dog. Exosomes and the MICA-NKG2D system in cancer. Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress. Pemetrexed-cisplatin combination in mesothelioma. MCI-186 inhibits tumor growth through suppression of EGFR phosphorylation and cell cycle arrest. The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro. P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma. Primary malignant peritoneal mesothelioma in an incarcerated groin hernia: report of a case. Mesothelioma of the tunica vaginalis testis: report of 2 cases with asbestos occupational exposure. Killing George with kindness--is there such a thing as too much palliative care? Asbestos-related diseases in Italy: epidemiologic evidences and public health issues. Validation of commonly used immunostains on cell-transferred cytologic specimens. Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma. Malignant peritoneal mesothelioma. Value of immunohistochemistry in confirming undifferentiated ovarian carcinomas. [Mesothelioma: the aetiological role of ultrathin fibres and repercussions on prevention and medical legal evaluation] Regulatory T Cells and Cytokines in Malignant Pleural Effusions Secondary to Mesothelioma and Carcinoma. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. [Development in the treatment of malignant mesothelioma] SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells. Thalidomide in patients with malignant pleural mesothelioma. Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Comparison of asbestos exposure assessments by next-of-kin respondents, by an occupational hygienist, and by a job-exposure matrix from the National Occupational Hazard Survey. Mesothelioma in household members of asbestos-exposed workers: 32 United States cases since 1990. [Acute respiratory distress syndrome following inhalation of barium sulphate.] Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. High-level detection of gene amplification and chromosome aneuploidy in extracted nuclei from paraffin-embedded tissue of human cancer using FISH: a new approach for retrospective studies. Cancer incidence and asbestos in drinking water, Town of Woodstock, New York, 1980-1998. Pemetrexed (Alimta) in small cell lung cancer. Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link? Evidence against a role for SV40 in human mesothelioma. Clinical course of thoracic cancers in Hodgkin's disease survivors. A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days. Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A. Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. Radiation injury to the liver after intensity-modulated radiation therapy in patients with mesothelioma: an unusual CT appearance. [Toxic optic neuropathy due to cisplatin therapy: a case report] Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Changing trends in US mesothelioma incidence. Cancer risks in a historical UK cohort of benzene exposed workers. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). [Lung cancer and peritoneal mesothelioma: two complications of asbestos exposure in the same patient] Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma. Abdominal mesothelioma in a goat. Pleural effusion: a structured approach to care. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells. Mesothelioma mortality in Great Britain from 1968 to 2001. [Diagnostic difficulties in primary mesothelioma] Farnesyltransferase inhibitors and human malignant pleural mesothelioma: a first-step comparative translational study. Pemetrexed therapy for malignant pleural mesothelioma. Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesothelioma. [The role of macrophages in asbestos-induced carcinogenesis] [Pleural mesothelioma--case with effusion in both pleural cavities] Analysis of Chromosomes 9 and 11 Aneuploidy Frequency in Pleural Effusion of Patients with and without Malignancy: Interphase FISH Technique. Cohort studies on cancer mortality among workers exposed only to chrysotile asbestos: a meta-analysis. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma. Malignant deciduoid mesothelioma: a diagnostic challenge. Identification of calretinin and the alternatively spliced form calretinin-22k in primary pleural mesotheliomas and in their metastases. Hyaluronan synthase expression in pleural malignant mesotheliomas. Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines. A case of primary malignant pericardial mesothelioma. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. [Management of malignant pleural effusions] [Second-line treatment of malignant pleural mesothelioma with Pemetrexed (Alimta) -- a case report] Municipal pleural cancer mortality in Spain. Comparison of monoclonal versus polyclonal calretinin antibodies for immunohistochemical diagnosis of malignant mesothelioma. Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study. Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors. Significance of immunocytochemical expression of E-cadherin, N-cadherin and CD44 in serous effusions using liquid-based cytology. Pemetrexed in malignant pleural mesothelioma. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Peritoneal biphasic mesothelioma in a dog. [A study on risk of malignant neoplasm and environmental exposure to crocidolite] Cancer mortality in a cohort of asbestos textile workers. Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells. Podoplanin as a marker for mesothelioma. Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review. Metastatic renal cell carcinoma presenting as multiple pleural tumours. Pathogenesis of malignant pleural mesothelioma. [Malignant mesothelioma of the pleura--diagnostic difficulties] Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization. Image cytometry: an aid for cytological diagnosis of pleural effusions. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion. Platinums: extending their therapeutic spectrum. Chemotherapy options and new advances in malignant pleural mesothelioma. Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients. Metastatic lung and pleural malignancy presenting as bilateral acute anterior uveitis. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Survey of the biological effects of refractory ceramic fibres: overload and its possible consequences. Invasive epithelial mesothelioma in a dog. Pemetrexed in malignant pleural mesothelioma. Biochemical pharmacology of pemetrexed. Malignant pleural mesothelioma. Automated matching of temporally sequential CT sections. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Malignant pleural mesothelioma in a woodchuck (Marmota monax). [Long-term prognostic analysis of patients with malignant pleural mesothelioma.] Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. [Primary malignant pericardial mesothelioma temporarily reduced by radiation therapy: a case report] [Diagnosis and treatment of 41 patients with malignant peritoneal mesothelioma] [A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP] Cadherin superfamily of adhesion molecules in primary lung cancer. Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. Rapid pleurodesis in symptomatic malignant pleural effusion. Mesothelioma pathogenesis, facts and expectations. Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma. [Primary pericardial malignant mesothelioma with incomplete endocardial cushion defect; report of a case] E-cadherin and cytokeratin subtype profiling in effusion cytology. Role of biochemical tests in the diagnosis of exudative pleural effusions. [How to identify an occupational exposure to carcinogens and in which cases?] [Asbestos-related occupational cancers] [Main carcinogens and epidemiology of occupational cancers] Fragile castles: the paradox of research politics, scientific progress, and the mutation of medical knowledge. Contested etiology: cancer risk among two Anatolian populations in Turkey and Europe. Malignant mesothelioma of the tunica vaginalis testis: a case with a predominant sarcomatous component. [Epidemiological investigation on the health status of employees in two factories manufacturing and repairing railway rolling stock: a historical perspective study of mortality] [Malignant mesothelioma of the pleura among women] Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Mortality updates (1970-1997) of two refinery/petrochemical plant cohorts at Baton Rouge, Louisiana, and Baytown, Texas. [Chemical pollution of indoor air and its effects on health] Primary synovial sarcoma of the pleura: beware of misdiagnosis. Ifosfamide, mesna, and interferon-alpha2A combination chemoimmunotherapy in malignant mesothelioma: results of a single center in central anatolia. Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategies. [Epitheliod mesothelioma of the atrioventricular node] Current chemotherapeutic treatment of malignant pleural mesothelioma. Mortality, morbidity, and asbestosis in New Zealand: the hidden legacy of asbestos exposure. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma. Auditing a new lung cancer service. Fibrinolysis of loculated pleural effusion in malignant mesothelioma. Double standards: the multinational asbestos industry and asbestos-related disease in South Africa. Patterns of failure following surgical resection for malignant pleural mesothelioma. Innovative therapies: photodynamic therapy. Innovative therapies: intraoperative intracavitary chemotherapy. External beam radiation therapy for the treatment of pleural mesothelioma. Multimodality therapy in mesothelioma: role of chemotherapy. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. Pleurectomy and decortication for malignant mesothelioma. Preoperative assessment and therapeutic options for patients with malignant pleural mesothelioma. Causality of mesothelioma: SV40 question. Evidence of an important role for SV40 in mesothelioma. Role of asbestos in etiology of malignant pleural mesothelioma. Epidemiology, biologic behavior, and natural history of mesothelioma. Genetics of malignant pleural mesothelioma: molecular markers and biologic targets. Pathology of mesothelioma. Malignant pleural mesothelioma: overview of the North American and European experience. Malignant pleural mesothelioma metastasis to the mandible. Population-based incidence and mortality cancer trends (1986-1997) from the network of Italian cancer registries. [Small bowel metastases from lung cancer] Nitric oxide production in fluoro-edenite treated mouse monocyte-macrophage cultures. Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB. [Spontaneous pneumothorax revealing malignant pleural mesothelioma. Three case reports] [An unusual diagnosis of post-traumatic hemothorax] In vivo optical imaging of pleural space drainage to lymph nodes of prognostic significance. HMBA induces cell death and potentiates doxorubicin toxicity in malignant mesothelioma cells. Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure. The loss of glypican-3 induces alterations in Wnt signaling. [Pleural mesothelioma and environmental exposure to mineral fibres: the case of a rural area in the Basilicata region, Italy] DNA damage in bronchial epithelial and mesothelial cells with and without associated crocidolite asbestos fibers. Synchronous bilateral malignant mesothelioma of tunica vaginalis testis: early diagnosis. [Malignant mesothelioma of the pleura in a worker with brief atypical exposure to chrysotile asbestos] [Geographical distribution of mortality from malignant pleural neoplasms and of former asbestos-exposed workers in the Campania Region] Cutting edge: tumor-specific CTL are constitutively cross-armed in draining lymph nodes and transiently disseminate to mediate tumor regression following systemic CD40 activation. Cerebral metastases in malignant mesothelioma: case report and literature review. Malignant mesothelioma as both a challenge and an opportunity. Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Presentation of malignant pleural mesothelioma with symptomatic brain metastasis: report of a case. [Diaphragm reconstruction after extrapleural pneumonectomy] [Multimodality therapy for diffuse malignant pleural mesothelioma] [Extrapleural pneumonectomy for malignant pleural mesothelioma] [Extrapleural pneumonectomy of malignant pleural mesothelioma] [Extrapleural pneumonectomy for malignant pleural mesothelioma and primary lung cancer] [Extrapleural pneumonectomy for thoracic malignancies] A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma. Immunolocalization of caveolin-1 in rat and human mesothelium. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Antiphospholipid syndrome associated with malignant mesothelioma presenting with superior vena cava thrombosis: a case report. Translation research: from accurate diagnosis to appropriate treatment. Peripheral lymphadenopathy as the initial manifestation of pericardial mesothelioma: a case report. [Solitary fibrous tumor of the pleura--description of two cases with features of malignancy] Beyond hematoxylin and eosin--the role of immunohistochemistry in surgical pathology. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Selected miscellaneous ovarian lesions: small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions. Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes. Chrysophiles versus chrysophobes: the white asbestos controversy, 1950s-2004. Infectious agents and cancer: criteria for a causal relation. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan. A mesothelial cyst of the round ligament presenting as an inguinal hernia after gonadotropin stimulation for in vitro fertilization. FDA drug approval summaries: pemetrexed (Alimta). Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion] Malignant mesothelioma surveillance: a comparison of ICD 10 mortality data with SEER incidence data in nine areas of the United States. Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Methodology for lognormal modelling of malignant pleural mesothelioma survival time distributions: a study of 5580 case histories from Europe and USA. The pathology associated with therapeutic procedures in malignant mesothelioma. [Pleural mesothelioma in women is associated with environmental exposure to asbestos] Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists. [Localized fibrous tumors of the pleura: clinical and surgical evaluation] Antitumor activity of the intratumoral injection of fowlpox vectors expressing a triad of costimulatory molecules and granulocyte/macrophage colony stimulating factor in mesothelioma. Malignant effusions: from diagnosis to biology. Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma. Pleural mesothelioma: little evidence, still time to do trials. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray. Malignant mesothelioma of the tunica vaginalis testis. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. 5-lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking. Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis. Diagnostic and prognostic value of Ki67 proliferation fraction in serous effusions. Retroperitoneal cystic masses: CT, clinical, and pathologic findings and literature review. Chronic inhalation toxicity and carcinogenicity study on potassium octatitanate fibers (TISMO) in rats. Is thoracoscopic talc pleurodesis really safe? Radiology in pleural disease: state of the art. Mesothelial cell proliferation and apoptosis. Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity. Automated lung segmentation for thoracic CT impact on computer-aided diagnosis. [Pleuromesothelioma -- psychology and pathogenesis] Pemetrexed in advanced NSCLC: a review of the clinical data. The emerging role of pemetrexed for the treatment of malignant mesothelioma. New investigative regimens and cytotoxic agents in thoracic cancers: gemcitabine and pemetrexed. Primary malignant mesothelioma of the greater omentum: report of a case. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells. Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma. Multicystic malignant mesothelioma of the tunica vaginalis with an unusually indolent clinical course. FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells. Biglycan is internalized via a chlorpromazine-sensitive route. Epidemiology of environmental and occupational cancer. [Experience with diagnosis and treatment of malignant peritoneal mesothelioma] The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma. Immunophenotypings of malignant epithelial mesothelioma and their roles in the differential diagnosis. Leptomeningeal metastasis from malignant pleural mesothelioma. Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology Group. Granulocyte-colony stimulating factor- and interleukin 6-producing diffuse deciduoid peritoneal mesothelioma. Asbestos-related pleural disease: value of dedicated magnetic resonance imaging techniques. [Malignant pleural mesothelioma in housewives in the province of Catania] Decreasing prevalence of pleural calcifications among Metsovites with nonoccupational asbestos exposure. [Survival analysis of malignant mesothelioma treated in Brescia, northern Italy, 1982-2000] Thoracic actinomycosis with mainly pleural involvement. The interaction of tenascin-C with fibronectin modulates the migration and specific metalloprotease activity in human mesothelioma cell lines of different histotype. Occupational respiratory disease in mining. Induction of 8-hydroxydeoxyguanosine by man made vitreous fibres and crocidolite asbestos administered intraperitoneally in rats. Occupational exposure to carbon black and risk of cancer. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine. Respiratory tract cancers: lung and mesothelioma. Chrysotile asbestos as a cause of mesothelioma: application of the Hill causation model. The epidemic of asbestos-related diseases in New Zealand. Asbestos in Italy. Asbestos in Scotland. The Dutch Institute for Asbestos Victims. Asbestos, asbestos-related diseases, and compensation claims in The Netherlands. Development of pericardial mesothelioma in golden retrievers with a long-term history of idiopathic haemorrhagic pericardial effusion. Airway obstruction complicating esophageal stent placement in two post-pneumonectomy patients. Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts. Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors. Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas. Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validation. Pemetrexed: a novel antifolate agent enters clinical practice. Malignant mesothelioma--the UK experience. Malignant mesothelioma. Medical oncology: standards, new trends, trials--the French experience. Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma. The role of Alimta in the treatment of malignant pleural mesothelioma: an overview of preclinical and clinical trials. Chemotherapy for malignant pleural mesothelioma: past results and recent developments. Considerations for post-operative radiotherapy to the hemithorax following extrapleural pneumonectomy in malignant pleural mesothelioma. Radiation therapy of mesothelioma: the Heidelberg experience and future aspects. Malignant mesothelioma--British surgical strategies. Asbestos: a clear and present danger--a UK perspective. Positron emission tomography in the diagnosis of mesothelioma. The use of magnetic resonance imaging in malignant mesothelioma. Diagnosis and staging of mesothelioma transthoracic ultrasound. Staging and response to therapy of malignant pleural mesothelioma. Prognostic factors in malignant mesothelioma. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma. Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance. Pathology of malignant mesothelioma. Pathological anatomy and molecular pathology. Epidemiology of pleural mesothelioma in Italy. Epidemiology of malignant mesothelioma in Australia. Malignant pleural mesothelioma in Turkey, 2000-2002. The epidemiology of asbestos-related diseases. Asbestos and mesothelioma in South Africa. Clear cell adenocarcinoma of the tunica vaginalis of the testis with an adjacent uterus-like tissue. [Malignant pleural mesothelioma: radiotherapy for the prevention of seeding nodules] Emergent human pathogen simian virus 40 and its role in cancer. Electromagnetic fields and health effects--epidemiologic studies of cancer, diseases of the central nervous system and arrhythmia-related heart disease. Phase II study of OK-432 intrapleural administration followed by systemic cisplatin and gemcitabine for non-small cell lung cancer with pleuritis carcinomatosa. Evaluation of malignant mesothelioma in central Anatolia: a study of 67 cases. Mortality from chronic obstructive pulmonary disease and pleural mesothelioma in an area contaminated by natural fiber (fluoro-edenite). Role of lateral cell-cell border location and extracellular/transmembrane domains in PECAM/CD31 mechanosensation. Simian virus 40 (SV40) and human cancer: a review of the serological data. [The association of lung cancer with asbestos and tobacco smoking] Pleural mesothelioma with cutaneous extension to chest wall scars. Chemotherapy and serum hyaluronic acid levels in malignant peritoneal mesothelioma. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval. Localised pleural malignant mesothelioma. Report of two cases simulating pulmonary carcinoma and review of the literature. [Lymphocyte and lymphocyte subsets in pleural fluid--comparison of malignant and non-malignant disorders] [Cardiac tumors. Experience with two cases] Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent. Mesothelin: a new target for immunotherapy. Determination of tumour prognosis based on angiogenesis-related vascular patterns measured by fractal and syntactic structure analysis. The debate on elder abuse for undertreated pain. Mesothelioma among brake mechanics: an expanded analysis of a case-control study. Nursing considerations for administering pemetrexed (Alimta) in combination with cisplatin for malignant pleural mesothelioma. Immunohistochemistry for the differentiation of peritoneal disseminated carcinoma of unknown origin. [Mesotheliomas with leucocytic infiltration] Simian virus 40 infection down-regulates the expression of nitric oxide synthase in human mesothelial cells. An intriguing case: malignant mesothelioma presenting as inguinal lymph node metastases. Ischemic heart disease mortality among heavy equipment operators. Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. [Insignificant carcinogenicity of chrysotile asbestos of the Ak-Dovurak deposits in Russia and its possible links] Gene expression profiles in human mesothelioma cell lines in response to interferon-gamma treatment. Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. Cardiac troponins I and T in dogs with pericardial effusion. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study. [Malignant mesothelioma--a diagnostic challenge] Role of 18F-FDG PET for evaluating malignant pleural mesothelioma. Lung cancer and mesothelioma among male automobile mechanics: a review. Giant mesenteric cyst of abdomen herniating into scrotum. Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. Well-differentiated papillary mesothelioma complicating endometrial carcinoma: a case report. Endometrial involvement by intra-abdominal diffuse malignant mesothelioma. The doctors and the dockers. [Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology] Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma. Expression of hyaluronan synthases and hyaluronan in malignant mesothelioma cells. Natural history of multifocal solitary fibrous tumors of the pleura: a 25-year follow-up report. Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments. Use of immunohistochemical marker calretinin in the diagnosis of a diffuse malignant metastatic mesothelioma in an equine. Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. Mesothelioma and lung cancer among motor vehicle mechanics: a meta-analysis. Establishment and characterization of a human malignant mesothelioma cell line (HMMME). alpha-Tocopheryl succinate inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors. Pulmonary fibre burden in sheep living in the Biancavilla area (Sicily): preliminary results. [Gene therapy in malignant mesothelioma] Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma. Peritoneal mesothelioma in a case of inguinal hernia. A review of the literature. [Benign peritoneal multicystic mesothelioma] [Obligation to report occupational diseases. Importance of external post-mortem examinations before cremation] Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Gene expression profiling identifies matriptase overexpression in malignant mesothelioma. [Surgery for malignant pleural mesothelioma] Malignant mesothelioma: risk factors and current management. Multimodal treatment for resectable epithelial type malignant pleural mesothelioma. Familial mesothelioma of the pleura--a report of 40 cases. Metastatic mesothelioma presenting with proptosis. Cellular potassium ion deprivation enhances apoptosis induced by cisplatin. Health and environmental consequences of the world trade center disaster. [Pleural mesothelioma: experience with 62 cases in 9 years] Pemetrexed in the treatment of advanced non-small-cell lung cancer: a review of the clinical data. Novel combinations using pemetrexed in malignant mesothelioma. Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma. Pharmacology and mechanism of action of pemetrexed. Pathogenesis of malignant mesothelioma. Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma. [Estimates of pleural mesothelioma incidence in the Lazio region (Italy), 1997-2000] [Assessment of asbestos exposure via mineralogical analysis of bronchoalveolar lavage fluid] Proteomic analysis of exosomes secreted by human mesothelioma cells. [Occupation related thoracic tumors] Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. [Etiological aspects of occupational cancer in printing industry] Significance of psammoma bodies in serous cavity fluid: a cytopathologic analysis. Calretinin gene promoter activity is differently regulated in neurons and cancer cells. Role of AP2-like cis element and zinc ions. Changing trends in US mesothelioma incidence. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Integration of multimodality approaches in the management of malignant pleural mesothelioma. The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature. High-grade neuroendocrine carcinoma of the lung presenting an unusual spread mimicking pleural mesothelioma associated with dermatomyositis. Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807). Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells. [Possibilities of diagnosis and treatment of malignant pleural mesothelioma] Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells. The diagnosis and attribution of asbestos-related diseases in an Australian context: report of the Adelaide Workshop on Asbestos-Related Diseases. October 6-7, 2000. Malignant pleural mesothelioma--an update. Global use of asbestos and the incidence of mesothelioma. [A case of splenic hemorrhage in the course of malignant mesothelioma] A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Asbestos-induced peritoneal mesothelioma in a construction worker. Identification of differentially expressed genes in murine mesothelioma cell lines of differing tumorigenicity using suppression subtractive hybridization. Therapy-induced thoracic malignancies. Laparoscopy and primary diffuse malignant peritoneal mesothelioma: a diagnostic challenge. Diffuse malignant epithelial peritoneal mesothelioma in pregnancy. A case report and literature review. Metastasis in pleural mesothelioma. Immunohistochemical markers for disseminated disease. High incidence of mesothelioma in an English city without heavy industrial use of asbestos. Recurrent solitary fibrous tumor of the pleura with malignant transformation. Ultrastructural and chromosomal studies on manganese superoxide dismutase in malignant mesothelioma. The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma. Occupational asbestos exposure and the incidence of non-Hodgkin lymphoma of the gastrointestinal tract: an ecologic study. Effects of asbestos on initiation of DNA damage, induction of DNA-strand breaks, P53-expression and apoptosis in primary, SV40-transformed and malignant human mesothelial cells. Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby, Montana. Patterns of lymphadenopathy in thoracic malignancies. Bayes without priors. Role of magnetic resonance imaging for evaluation of tumors in the cardiac region. Cancer mortality and morbidity among Lithuanian asbestos-cement producing workers. Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells. Behaviour of the new asbestos amphibole fluor-edenite in different lung cell systems. Squamous cell carcinoma of the lung producing granulocyte colony-stimulating factor and resembling a malignant pleural mesothelioma. Multiple endocrine neoplasia type 1 with unusual concomitance of various neoplastic disorders. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: a future drug against a fatal neoplastic disease? The asbestos cancer epidemic. The Mesothelioma epidemic in Western Europe: an update. Factors influencing long-term survival in mesothelioma patients--results of the German mesothelioma register. [A meta-analysis of cohort studies on cancer mortality among workers exposure to chrysotile fiber alone] Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells. Malignant mesothelioma presenting as stroke--a case report. Antiangiogenic drugs and current strategies for the treatment of lung cancer. [Gastrointestinal stromal tumor of the omentum: report of a case] [Localized fibrous mesothelioma with bloody pleural effusion; report of a case] Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers. Proteomic analysis of exosomes isolated from human malignant pleural effusions. History of asbestos related disease. Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention. Volume-regulated Cl- channels in human pleural mesothelioma cells. Gene expression profiles predict survival and progression of pleural mesothelioma. Mesothelioma trends in the Republic of Ireland: an epidemiologic study in the context of the causal pathway. Mesothelioma following exposure to asbestos used in sugar refineries: report of two cases and review of the literature. Changing patterns in asbestos-induced lung disease. [Asbestos risk in the textile industry: final confirmation of data from the Lombardy Mesothelioma Registry]
